Healthtech company Navina raises US$22m to advance primary care

The healthtech company Navina has announced a US$22m Series B funding round to transform primary care using AI, taking the total investment to US$44m.

Navina uses medically-informed AI to make sense of the increasing amounts of data primary care physicians collect, aiming to transform the provider-patient interaction.

The developers say the platform is able to put the right information in front of physicians by analysing patient histories and give them a deep understanding of their patients as well as actionable insights at the point of care.

This, Navina argues, creates a cascade of benefits, solving the interconnected problems of data overload and dangerous physician burnout that lead to clinical misses and suboptimal care.

The new funding,  led by ALIVE Israel HealthTech Fund, will be used to accelerate growth and adoption of the company’s platform among US physician groups and the enterprise healthcare market.

The company will further invest in its AI technology and clinical algorithms, and expand its integration of more emerging data sources to support physicians.

In the past year, the platform expanded its footprint to include not only physicians but also their supporting staff, aligning workflows across all stakeholders in their common goal of effectively serving their patient populations and improving value-based care.

Navina’s effectiveness was recently validated by a report issued by the Innovation Lab of the American Academy of Family Physicians, which found the platform increases diagnosis accuracy, as well reduces pre-visit preparation time by 61 per cent.

Professor Ari Shamiss, ALIVE’s managing general partner who will join Navina’s Board of Directors, said: “Navina’s growth has been remarkable. They have achieved penetration levels among advanced primary care groups in the United States at a pace that we have seldom seen, and our aim is to further support the company’s accelerated growth.

“They are clearly addressing a gaping, unmet quadruple need: to meet the aims of improving population health, patient experience, clinician well-being and productivity – all while improving economics. This is being validated every day.”

Ronen Lavi, co-founder and CEO of Navina, said: “We welcome ALIVE into our family of investors, and are gratified by the continued support of our initial investor group.

“Our mission, from the beginning, has been to give physicians the time and confidence they need to stay ahead of their patients’ health, and to transform the physician-patient interaction, changing it from reactive to proactive.

“As Israel’s top HealthTech fund, whose leaders are former directors of the country’s largest hospitals and medical centres and accomplished investors, ALIVE is the ideal partner for this journey.”